Log In
BCIQ
Print this Print this
 

Tetmodis, tetrabenazine

  Manage Alerts
Collapse Summary General Information
Company AOP Orphan Pharmaceuticals AG
DescriptionSelective inhibitor of vesicular monoamine transporter (VMAT2)
Molecular Target Vesicular monoamine transporter 2 (VMAT2) (SLC18A2)
Mechanism of ActionVesicular monoamine transporter 2 inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today